Heidelberg Epignostix GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Heidelberg Epignostix GmbH - overview
Established
2022
Location
Heidelberg, -, Germany
Primary Industry
Biotechnology
About
Founded in 2022 and based in Heidelberg, Germany, Heidelberg Epignostix GmbH operates as a biotechnology company that uses technology to develop cancer patients' diagnostics. In July 2024, Heidelberg Epignostix GmbH raised EUR 4. 3 million in seed funding from investors. As of 2024, the company is led by its CEO, David T.
W. Jones. The company specializes in the research and development, certification, and marketing of software solutions designed for molecular tumor classification. These solutions utilize DNA methylation profiling and advanced machine learning algorithms to achieve precise and accurate cancer diagnosis.
The firm’s core offering is its technology in DNA methylation analysis. This technology enables the classification of tumors at a molecular level, providing critical insights that can inform personalized treatment plans. In addition, Heidelberg’s pipeline also includes sarcoma classifiers, more classifiers, and nanopore classifiers, which are under development and will offer tailored treatment strategies and improved patient outcomes. The organization plans to use the July 2024 funding to drive market development for its primary indication for brain tumor classification.
Current Investors
LBBW Venture Capital, High-Tech Gruenderfonds, MBG Baden-Wuerttemberg
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.epignostix.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.